SMAD3 and hepatocellular carcinoma: Our lab has previous reported SMAD3 promoted HCC metastasis by upregulating protein tyrosine phosphatase receptor epsilon (PTPRε) expression and high expression of SMAD3 was associated with poor prognosis in HCC [13], but the impacts of SMAD2 on HCC remain largely unclear.